Janelle Goulard

Dioseve develops technologies to create fertilizable eggs from iPS cells / ES cells. By providing oocytes for couples who cannot give birth, we aim to establish unprecedented infertility treatment.

We work to map the microbiome and illuminate interactions foundational to the health of humanity.

Carbon Project Development For a Sustainable Future. Biodel AG is dedicated to improving farm incomes, soil health, and sequestering carbon from the atmosphere.

The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohns, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still arent real solutions for dysbiosis. And since dysbiosis is the result of changes to the 1000s different microbes of our gut it is nearly impossible to find the right remedy for your specific dysbiosis. Sun Genomics is empowering the consumer to educate themselves about their microbiome signature and make informed, as well as transparent, product selections to manage their dysbiosis. We are helping consumers realize the power of their microbiota through genomics, probiotics, microbiology, informatics, and software.

Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.

Dioseve develops technologies to create fertilizable eggs from iPS cells / ES cells. By providing oocytes for couples who cannot give birth, we aim to establish unprecedented infertility treatment.

We work to map the microbiome and illuminate interactions foundational to the health of humanity.

Carbon Project Development For a Sustainable Future. Biodel AG is dedicated to improving farm incomes, soil health, and sequestering carbon from the atmosphere.

The microbiome is the new frontier gut health and changes to your microbiome signature is now being understood as a central conduit of health and disease. IBD, IBS, Crohns, colitis, type I diabetes, arthritis, metabolic syndrome, and several autoimmune disorders have all been associated with microbiome changes also known as dysbiosis. When you total the number of individuals affected by these diseases, over 80% Americans suffer from dysbiosis annually. With this much science there still arent real solutions for dysbiosis. And since dysbiosis is the result of changes to the 1000s different microbes of our gut it is nearly impossible to find the right remedy for your specific dysbiosis. Sun Genomics is empowering the consumer to educate themselves about their microbiome signature and make informed, as well as transparent, product selections to manage their dysbiosis. We are helping consumers realize the power of their microbiota through genomics, probiotics, microbiology, informatics, and software.

For over 20 years, Pangaea Ventures has been at the forefront of hard tech innovation. We leverage our expertise to support groundbreaking companies that have the potential to reshape industries and solve for some of the planets biggest problems. We seek to generate meaningful returns for our investors by backing breakthrough innovations that deliver transformative solutions for planetary health.